Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | PRAX | KYMR | ||
| Company | Repligen Corp | Praxis Precision Medicines Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.66 | 370.35 | 122.87 | ||
| High | 182.43 | 387.99 | 125.71 | ||
| Low | 175.74 | 365.37 | 119.77 | ||
| Last | 181.13 | 375.94 | 119.80 | ||
| Change | +0.84 | +11.36 | -1.70 | ||
| Percent Change | +0.47% | +3.12% | -1.40% | ||
| Volume | 1,097,200 | 413,300 | 503,400 | ||
| 20-Day Average Volume | 1,136,360 | 449,265 | 670,660 | ||
| Previous | 180.29 | 364.58 | 121.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 159.10 | 345.81 | 111.57 | ||
| 20-Day Raw Stochastic | 87.05% | 84.00% | 72.84% | ||
| 20-Day Relative Strength | 72.23 | 58.59 | 59.99 | ||
| Weighted Alpha | +55.22 | +155.61 | +138.10 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 88% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 72% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.57% since 08/14/26 | +2.49% since 08/14/26 | +2.05% since 08/14/26 | ||
| Low | 164.62 on 08/17/26 | 361.16 on 08/20/26 | 117.04 on 08/17/26 | ||
| High | 188.73 on 08/20/26 | 392.70 on 08/20/26 | 127.36 on 08/19/26 | ||
| 1-Month | |||||
| %Chg | +32.22% since 07/21/26 | +18.27% since 07/21/26 | +5.67% since 07/21/26 | ||
| Low | 130.03 on 07/27/26 | 287.93 on 07/29/26 | 99.52 on 08/03/26 | ||
| High | 188.73 on 08/20/26 | 392.70 on 08/20/26 | 127.36 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | +59.77% since 05/21/26 | +7.24% since 05/21/26 | +48.62% since 05/21/26 | ||
| Low | 112.00 on 05/27/26 | 238.77 on 06/10/26 | 69.48 on 06/03/26 | ||
| High | 188.73 on 08/20/26 | 392.70 on 08/20/26 | 130.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +33.50% since 02/20/26 | +12.13% since 02/20/26 | +37.07% since 02/20/26 | ||
| Low | 100.99 on 05/14/26 | 238.77 on 06/10/26 | 69.48 on 06/03/26 | ||
| High | 188.73 on 08/20/26 | 392.70 on 08/20/26 | 130.05 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,174,846 | 10,179,073 | 10,102,847 | ||
| Shares Outstanding, K | 56,436 | 27,920 | 83,151 | ||
| Annual Sales, $M | 738,260,000 | 0 | 39,210,000 | ||
| Annual Net Income, $M | 48,890,000 | -303,270,000 | -311,350,000 | ||
| Last Qtr Sales, $M | 204,130,000 | 0 | 65,000,000 | ||
| Last Qtr Income, $M | 5,010,000 | -83,720,000 | -61,210,000 | ||
| 60-Month Beta | 1.03 | 2.78 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.54 on 07/28/26 | -2.87 on 08/06/26 | -0.62 on 08/05/26 | ||
| Latest Earnings Date | 10/27/26 | 11/04/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 89.52 | 0.00 | 0.00 | ||